Independent · Reader-funded · FTC-compliant affiliate disclosureVol. II · No. 17 April 23, 2026
Live
BPC-157 $5.65/mg 3.2%|Tirzepatide $10.00/mg 8.1%|Semaglutide $8.85/mg 5.4%|Retatrutide $19.00/mg 2.1%|TB-500 $8.00/mg 1.2%|MOTS-C $8.00/mg 2.0%
metabolic

Retatrutide

Triple GLP-1 / GIP / glucagon agonist (investigational)

Cheapest offer
$8.02/mg
2 vendors tracked5 live pricesLast crawl: 2026-04-23 22:16 UTC
About

Retatrutide is an investigational triple-agonist at GLP-1, GIP, and glucagon receptors, currently in Phase 3 trials. Research-grade is widely available ahead of commercial approval.

Also known as: LY3437943

Retatrutide · 10mg

1 vendors
VendorGradeRiskPrice$/mgStock
Australian Peptide Store
AU
B-Watch
$103.99
◎ Best $/mg
$10.40In stockBuy with code →
Sorted by $/mg ascendingLast crawl 2026-04-22 · Demo data

Retatrutide · 15mg

1 vendors
VendorGradeRiskPrice$/mgStock
Australian Peptide Store
AU
B-Watch
$136.49
◎ Best $/mg
$9.10In stockBuy with code →
Sorted by $/mg ascendingLast crawl 2026-04-22 · Demo data

Retatrutide · 20mg

2 vendors
VendorGradeRiskPrice$/mgStock
Australian Peptide Store
AU
B-Watch
$162.49
◎ Best $/mg
$8.12In stockBuy with code →
Nexus Peptides
US
BOperational
$249.99
53.8%
$12.50In stockVisit →
Sorted by $/mg ascendingLast crawl 2026-04-22 · Demo data

Retatrutide · 30mg

1 vendors
VendorGradeRiskPrice$/mgStock
Australian Peptide Store
AU
B-Watch
$240.49
◎ Best $/mg
$8.02In stockBuy with code →
Sorted by $/mg ascendingLast crawl 2026-04-22 · Demo data
Related peptides